An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development

Bridging traditional mouse malaria models and human trials

Ryan W.J. Steel, Stefan H.I. Kappe, Brandon Wilder

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Malaria remains a significant public health burden with 214 million new infections and over 400,000 deaths in 2015. Elucidating relevant Plasmodium parasite biology can lead to the identification of novel ways to control and ultimately eliminate the parasite within geographic areas. Particularly, the development of an effective vaccine that targets the clinically silent pre-erythrocytic stages of infection would significantly augment existing malaria elimination tools by preventing both the onset of blood-stage infection/disease as well as spread of the parasite through mosquito transmission. In this Perspective, we discuss the role of small animal models in pre-erythrocytic stage vaccine development, highlighting how human liver-chimeric and human immune system mice are emerging as valuable components of these efforts.

Original languageEnglish (US)
Pages (from-to)1563-1579
Number of pages17
JournalFuture Microbiology
Volume11
Issue number12
DOIs
StatePublished - Dec 1 2016
Externally publishedYes

Fingerprint

Malaria Vaccines
Malaria
Parasites
Vaccines
Infection
Plasmodium
Human Development
Culicidae
Immune System
Animal Models
Public Health
Liver

Keywords

  • antigen identification
  • cellular and humoral immunity
  • human immune system mice
  • human liver-chimeric mice
  • in vitro assays
  • malaria
  • Plasmodium
  • pre-erythrocytic vaccine
  • whole-sporozoite immunization

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development : Bridging traditional mouse malaria models and human trials. / Steel, Ryan W.J.; Kappe, Stefan H.I.; Wilder, Brandon.

In: Future Microbiology, Vol. 11, No. 12, 01.12.2016, p. 1563-1579.

Research output: Contribution to journalReview article

@article{71e17622fdf746639315150e88f29b77,
title = "An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development: Bridging traditional mouse malaria models and human trials",
abstract = "Malaria remains a significant public health burden with 214 million new infections and over 400,000 deaths in 2015. Elucidating relevant Plasmodium parasite biology can lead to the identification of novel ways to control and ultimately eliminate the parasite within geographic areas. Particularly, the development of an effective vaccine that targets the clinically silent pre-erythrocytic stages of infection would significantly augment existing malaria elimination tools by preventing both the onset of blood-stage infection/disease as well as spread of the parasite through mosquito transmission. In this Perspective, we discuss the role of small animal models in pre-erythrocytic stage vaccine development, highlighting how human liver-chimeric and human immune system mice are emerging as valuable components of these efforts.",
keywords = "antigen identification, cellular and humoral immunity, human immune system mice, human liver-chimeric mice, in vitro assays, malaria, Plasmodium, pre-erythrocytic vaccine, whole-sporozoite immunization",
author = "Steel, {Ryan W.J.} and Kappe, {Stefan H.I.} and Brandon Wilder",
year = "2016",
month = "12",
day = "1",
doi = "10.2217/fmb-2016-0077",
language = "English (US)",
volume = "11",
pages = "1563--1579",
journal = "Future Microbiology",
issn = "1746-0913",
publisher = "Future Medicine Ltd.",
number = "12",

}

TY - JOUR

T1 - An expanding toolkit for preclinical pre-erythrocytic malaria vaccine development

T2 - Bridging traditional mouse malaria models and human trials

AU - Steel, Ryan W.J.

AU - Kappe, Stefan H.I.

AU - Wilder, Brandon

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Malaria remains a significant public health burden with 214 million new infections and over 400,000 deaths in 2015. Elucidating relevant Plasmodium parasite biology can lead to the identification of novel ways to control and ultimately eliminate the parasite within geographic areas. Particularly, the development of an effective vaccine that targets the clinically silent pre-erythrocytic stages of infection would significantly augment existing malaria elimination tools by preventing both the onset of blood-stage infection/disease as well as spread of the parasite through mosquito transmission. In this Perspective, we discuss the role of small animal models in pre-erythrocytic stage vaccine development, highlighting how human liver-chimeric and human immune system mice are emerging as valuable components of these efforts.

AB - Malaria remains a significant public health burden with 214 million new infections and over 400,000 deaths in 2015. Elucidating relevant Plasmodium parasite biology can lead to the identification of novel ways to control and ultimately eliminate the parasite within geographic areas. Particularly, the development of an effective vaccine that targets the clinically silent pre-erythrocytic stages of infection would significantly augment existing malaria elimination tools by preventing both the onset of blood-stage infection/disease as well as spread of the parasite through mosquito transmission. In this Perspective, we discuss the role of small animal models in pre-erythrocytic stage vaccine development, highlighting how human liver-chimeric and human immune system mice are emerging as valuable components of these efforts.

KW - antigen identification

KW - cellular and humoral immunity

KW - human immune system mice

KW - human liver-chimeric mice

KW - in vitro assays

KW - malaria

KW - Plasmodium

KW - pre-erythrocytic vaccine

KW - whole-sporozoite immunization

UR - http://www.scopus.com/inward/record.url?scp=84999018315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84999018315&partnerID=8YFLogxK

U2 - 10.2217/fmb-2016-0077

DO - 10.2217/fmb-2016-0077

M3 - Review article

VL - 11

SP - 1563

EP - 1579

JO - Future Microbiology

JF - Future Microbiology

SN - 1746-0913

IS - 12

ER -